Literature DB >> 26967258

Incidence and Management of Glaucoma in Vogt Koyanagi Harada Disease.

Amit Pandey1, Shantha Balekudaru, Devendra V Venkatramani, Amala E George, Vijaya Lingam, Jyotirmay Biswas.   

Abstract

PURPOSE: To analyse the prevalence, incidence, and risk factors of glaucoma in Vogt Koyanagi Harada (VKH) disease and study the changes in visual acuity and intraocular pressure (IOP) with treatment.
MATERIALS AND METHODS: Retrospective chart analysis of 448 eyes of 224 patients of Indian origin diagnosed with VKH disease from January 1990 to December 2013, who had a minimum follow-up of 3 months was performed.
RESULTS: Seventy-one eyes (15.8%) developed sustained elevation in IOP. The prevalence of glaucoma at presentation was 15.8% and the cumulative incidence of glaucoma was 11.7%. The mechanisms of glaucoma were open-angle glaucoma in 46 eyes, (64.8%), angle closure in 21 eyes (29.6%), and of combined mechanisms in the remainder (4 eyes, 5.6%). Acute angle-closure crisis developed in 9 eyes (12.6%). Uveal effusion (odds ratio 9.47; confidence interval, 4.08-20.03) and increased number of recurrences (odds ratio 1.31; confidence interval, 1.13-1.53) were found to be significant risk factors for the development of glaucoma. Successful control of IOP was achieved in 64% at 12 months using medical/ laser treatment for glaucoma and was 50 % at 12 months following surgical management.
CONCLUSIONS: Glaucoma is a frequent complication of uveitis in VKH disease. Presence of uveal effusion and increased number of recurrences of inflammation are significant risk factors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26967258     DOI: 10.1097/IJG.0000000000000400

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  5 in total

1.  Comment on: Relative changes in luminal and stromal areas of choroid determined by binarization of EDI-OCT images in eyes with Vogt-Koyanagi-Harada disease after treatment.

Authors:  Salih Uzun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-15       Impact factor: 3.117

2.  Aqueous proinflammatory cytokines in acute primary angle-closure eyes.

Authors:  Yao-Ming Liu; Shi-Da Chen; Xing-Yi Li; Wen-Bin Huang; Fei Li; Jia-Wei Wang; Ying-Qi Li; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

3.  High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease.

Authors:  Carlos Alvarez-Guzman; Jorge E Valdez-Garcia; Raul E Ruiz-Lozano; Alejandro Rodriguez-Garcia; Carlos F Navas-Villar; Curt Hartleben-Matkin; Miguel Pedroza-Seres
Journal:  Int Ophthalmol       Date:  2022-07-05       Impact factor: 2.031

Review 4.  Vogt-Koyanagi-Harada syndrome - current perspectives.

Authors:  Abeir Baltmr; Sue Lightman; Oren Tomkins-Netzer
Journal:  Clin Ophthalmol       Date:  2016-11-24

5.  Vogt-Koyanagi-Harada disease: a retrospective and multicentric study of 41 patients.

Authors:  K Diallo; S Revuz; G Clavel-Refregiers; T Sené; C Titah; M Gerfaud-Valentin; P Seve; R Jaussaud
Journal:  BMC Ophthalmol       Date:  2020-10-07       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.